Xbrane Biopharma Ab (F7XB)

  0.02
   
  • Change Today:
     0.00
  • 52 Week High:  0.03
  • 52 Week Low:  0.00
  • Currency: Euro
  • Volume: 0
Select chart: 1 week | 1 month | 3 month | 6 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue (krm) Pre-tax (krm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 582.50 366.00 n/a n/a n/a n/a n/a 0.0%
31-Dec-26 381.50 136.50 n/a n/a n/a n/a n/a 0.0%
31-Dec-27 734.00 373.00 n/a n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Forecast Ratios

Year Ending Revenue/Share Price/Revenue per Share
31-Dec-25 n/a n/a
31-Dec-26 n/a n/a
31-Dec-27 n/a n/a

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (krm)
31-Dec-2025 582 n/a n/a n/a 460 680
31-Dec-2026 382 n/a n/a n/a 844 1,122
31-Dec-2027 734 n/a n/a n/a n/a n/a
 
Earnings
31-Dec-2025 n/a n/a n/a n/a n/a n/a
31-Dec-2026 n/a n/a n/a n/a n/a n/a
31-Dec-2027 n/a n/a n/a n/a n/a n/a
 
Dividend
31-Dec-2025 n/a n/a n/a n/a n/a n/a
31-Dec-2026 n/a n/a n/a n/a n/a n/a
31-Dec-2027 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 0 0 0 0 0 0
Buy 1 1 1 1 1 1
Neutral 1 1 1 1 1 1
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 2 2 2 2 2 2
 
Average Rec 6.25 6.25 6.25 6.25 6.25 6.25

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

F7XB Market Data

Currency Euro
Share Price   0.02
Change Today   0.00
% Change -0.64 %
52 Week High  0.03
52 Week Low  0.00
Volume 0

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page